It’s estimated that in Poland alone, there are more than two and a half million diabetic patients, 200,000 of which are patients with type 1 diabetes. According to WHO’s statistics, by 2030 these numbers will double. The way to fight the disorder, is pancreas or islets of Langerhans transplantation, although it’s immensely tough and demanding. Can we change it? Yes, we can, by creating bionic pancreas.
If the program succeedes, what we of course count on, in 3 years time scientists will be prepared to carry out first trials with the participation of patients. We can see that many diabetics look at our work with hope, giving us strength and willingness to act. I would like to point out that this type of research is unique on a global scale. Moreover, Polish Bionic Consortium is among the leaders of centers dealing with this subject.
MD, PhD Michal Wszola
The complexity and risikiness of pancreas transplantation process is not the only concern. Other issues are also caused by the shortage of organs for transplantation, due to the fact that it’s possible to transplant only as many organs, as can be taken from the deceased/donors. Our project eliminates this problem. Tissue bioprinting is an increasingly popular method used in experimental medicine. Moreover, 3D printed trachea and bladder have already been successfully transplanted. It’s time for a fully-functioning organ.
Current research is carried out by Bionic Consortium led by Foundation of Research and Science Development. Other members of the consortium are: Warsaw University of Technology, Warsaw Medical University, Nencki Institute of Experimental Biology, Polish Academy of Science, Jesus Child Hospital and MediSpace Ltd.